Indian pharma urged to invest in R&D. The U.S. Food and Drug Administration (USFDA) will continue to scrutinize Indian pharmaceutical companies and their products, unless the quality of manufacturing is raised, says an industry report by S&P Global Ratings. “We...
Read moreDetails

